(Jan 17): Unilever Plc would need to raise its bid for GlaxoSmithKline Plc's consumer health-care unit by about 7.3 billion pounds (US$10 billion) to have a hope of winning the backing of GSK's board, according to analysts, traders and brokers polled by Bloomberg News.
A bump to 57.3 billion pounds is needed, based on the average estimate from 11 analysts, traders and brokers in Bloomberg's informal survey, with predictions ranging from 54 billion pounds to 65 billion pounds. Glaxo, which said in December it would spin off the business, rejected three bids from Unilever, with the last at about 50 billion pounds.
While Unilever could increase its offer to about 55 billion pounds, "we are very doubtful this will be sufficient to persuade the GSK board or GSK investors," analysts at Citigroup Inc. wrote in a report Monday. The stock component of the offer, plus the tax bill that Glaxo would face on the cash proceeds, are among the reasons it may not go for the deal, they wrote.
Morgan Stanley's event-driven desk sees an enterprise value for the Glaxo consumer health-care unit of 59 billion pounds to 72 billion pounds, assuming growth of 4% to 6%. Given that, it's clear why Glaxo and minority partner Pfizer Inc. rejected offers up to 50 billion pounds.
Speculation that they would be more open to a price in the region of 60 billion pounds would make sense, the Morgan Stanley event-driven desk said.
Taking an improved bid for the consumer business — instead of a midyear initial public offering — would serve Glaxo better, giving it firepower to boost its drug pipeline, said Bloomberg Intelligence analyst John Murphy.
Unilever has held talks with banks about additional financing for a potential sweetened offer for the Glaxo unit, according to people familiar with the matter. Analysts who follow Unilever scorned the proposed acquisition, saying it doesn't make sense and would be too expensive.
- The Bidens May Pose 'Security Problem' to US & Hunter Was Likely Used as 'Bagman', Analyst Says
- COVID-19 Impact | Seven ways the pandemic has changed how we shop for food
- SoftBank takes $10 billion hit after being unmasked as Nasdaq 'whale'
- China's $1.5 million digital currency giveaway impresses analysts but not shoppers: Report
- Alaska Airlines follows United, Delta and American in scrapping hefty flight change fees for economy and premium seats to aid pandemic bounce-back - but goes one step further by extending policy change to ALL international flights
- What you need to know about coronavirus on Tuesday September 8
- TJ Finley cool, calm, collected in debut win, but LSU has no quarterback controversy
- Sports news feed: Naomi Osaka wins US Open
- Marcus Rashford seeks more change after food voucher win
- Final Trump vs Biden Debate: Rule Changes, Hunter's Emails & Last Battle for Seven Key Swing States
- How The Recession Could Help Uber Win Its Fight To Stop Drivers Becoming Employees
- What you need to know about buying an electric car: Your guide to pure electric and hybrid cars and the best new models arriving in showrooms
- Labor Day Win: CEOs Hire Americans Because Donald Trump Excludes Visa Workers
- Alphabet sales growth revived as advertisers flock back to Google
- Marcus Rashford 2 Boris Johnson 0: Man Utd star is set to force PM into ANOTHER U-turn on free meals during school holidays - as hundreds of restaurants, cafes and volunteers line up behind his campaign and offer THOUSANDS of packed lunches
- Trump admits downplaying virus, but told Woodward it was "deadly"
- Daily Briefing: Asking for more stimulus?
- USA's Ali Khan in the fast lane to T20 stardom
- UK secures agreement with Japan on first post-Brexit trade deal
- Presidential Debate Live Updates: Trump and Biden Face Off For Final Time Before Election
Unilever needs seven-billion pound bump to win Glaxo unit, analysts say have 598 words, post on www.theedgemarkets.com at January 17, 2022. This is cached page on Business News. If you want remove this page, please contact us.